China NT Pharma Group Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China NT Pharma Group Co Ltd with three other
companies in this sector in China:
Tibet Rhodiola Pharmaceutical Holding Company
sales of 1.38 billion Chinese Renmimbi [US$204.79 million]
of which 62%
was Pharmaceutical Business Trade),
GuangYuYuan Chinese Herbal Medicine Co Ltd
(426.25 million Chinese Renmimbi [US$63.23 million]
of which 79%
was Drug Industry), and
Kingworld Medicines Group Limited
(713.55 million Chinese Renmimbi [US$105.85 million]
During the year ended December of 2015, sales at
China NT Pharma Group Co Ltd were 847.73 million Chinese Renmimbi (US$125.76 million).
decrease of 2.0%
versus 2014, when the company's sales were 864.62 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 10.8% decline
in Third-Party Pharnaceutical Promotion and S, from 706.43 million Chinese Renmimbi to 630.42 million Chinese Renmimbi.
However, these declines were partially offset by the increase in sales of
Proprietary Products Production and Sales (up 38.1% to 217.30 million Chinese Renmimbi)